IJCRR - Vol 07 Issue 14, July, 2015
IL-3 AND GM-CSF INDUCES INCREASED RECRUITMENT OF LYMPHOCYTES IN PERIPHERAL BLOOD IN ENU INDUCED LEUKEMIA MOUSE MODEL
Author: Ashish Kumar Singha, Bhaskar Bhattacharjee, Debasish Maiti
Aim: The enrolment of blood progenitor cells from the bone marrow into peripheral blood or mobilization is required in leukemia following treatment with chemotherapy and/or cytokines. In this experiment, we examined the mobilization of lymphocytes from bone marrow to peripheral blood using interleukin-3 (IL-3) and granulocyte monocyte-colony stimulating factor (GM-CSF) in experimentally induced leukemia model.
Methods: In our Laboratory, leukemia is induced in Balb/C mice by challenging with N’-N’ Ethylnitrosourea (ENU) at the dose of 80mg/kg body twice in one week interval and confirmed by staining of peripheral blood and bone marrow smear. After confirmation of leukemia induction, animals were received rmIL-3 and rmGM-CSF in combination for consecutive four days. Leishman’s staining of peripheral blood smear and isolation of lymphocytes by percoll gradient method used in this study to determine the cell count.
Results: Total leukocyte count exhibits 6 folds higher in number in leukemia group compared to control group. After combination of treatment the total leukocyte count was same as leukemic control group until the sacrifice of animals. But the lymphocyte count increased around 2.6 fold after combination of IL-3 and GM-CSF treatment to leukemic mice.
Conclusion: This data suggests the mobilization of lymphocytes from bone marrow to peripheral blood may be immunologically beneficial to combat against tumor cells
Keywords: Mobilization, Leukemia, ENU, interleukin-3, Granulocyte monocyte colony, Stimulating factor
Ashish Kumar Singha, Bhaskar Bhattacharjee, Debasish Maiti. IL-3 AND GM-CSF INDUCES INCREASED RECRUITMENT OF LYMPHOCYTES IN PERIPHERAL BLOOD IN ENU INDUCED LEUKEMIA MOUSE MODEL International Journal of Current Research and Review. Vol 07 Issue 14, July, 49-53
1. Aerts J G, and. Hegmans J P. Tumor-specific cytotoxic T cells are crucial for efficacy of immunomodulatory antibodies in patients with lung cancer. Cancer Res. 2013; 73(8): 2381-2388.
2. Arellano M, Lonial S. Clinical uses of GM-CSF, a critical appraisal and update. Biologics: Targets and Therapy 2008: 2(1): 13–27.
3. Chatterjee R, Chattopadhyay S, Sanyal S, Daw S, Law S. Pathophysiological Scenario of Hematopoietic Disorders: A Comparative Study of Aplastic Anemia, Myelodysplastic Syndrome and Leukemia in Experimental Animals. Proc Zool Soc. 2015.
4. Depamede NS. Assessment of the purity and characteristics of rat splenic T cells isolated by one-step discontinuous gradient of percoll. JITV 2010; 15(2): 157-164.
5. Dilloo D, Dirksen U, Schneider M, Zessack N, Buttlies B, Levitt L, Burdach S. Differential production of interleukin-3 in human T lymphocytes following either CD3 or CD2 receptor activation. Exp Hematol. 1996; 24(4): 537-43.
6. Fu P, Bagai RK, Meyerson H, Kane D, Fox RM, Creger RJ, et al. Pre-mobilization therapy blood CD34 cell count predicts the likelihood of successful hematopoietic stem cell mobilization. Bone Marrow Transplantation 2006; 38: 189–196.
7. Ganser A, Siepelt G, Lindeman A, Ottmann OG, Falk S, Eder S, et al. Effect of recombinant human interleukin 3 in patients with myelodysplastic syndrome. Blood 1990; 76: 455.
8. Groscurth P, Filgueira L et al. Killing mechanisms of cytotoxic T lymphocytes. News Physiol Sci. 1998; 13: 17-21.
9. Hariharan K, Braslawsky G, Black A, Raychaudhuri S, Hanna N. The induction of cytotoxic T cells and tumor regression by soluble antigen formulation. Cancer Res. 1995; 55: 3486-3489.
10. Hoggatt J, Pelus LM. Mobilization of hematopoietic stem cells from the bone marrow niche to the blood compartment. Stem Cell Research and Therapy 2011; 2:13.
11. Kapustay PM. Blood cell transplantation: concepts and concerns. Semin Oncol Nurs. 1997; 13(3):151-163.
12. Kmieciak M, Worschech A, Nikizad H, et al. CD4+ T cells inhibit the neu-specific CD8+ T-cell exhaustion during the priming phase of immune responses against breast cancer. Breast Cancer Res Treat, 2011. 126(2): 385-94.
13. Law S, Maiti D, Palit A, Majumder D, Basu K, Chaudhuri S, Chaudhuri S. Facilitation of functional compartmentalization of bone marrow cells in leukemic mice by biological response modifiers: an immunotherapeutic approach. Immunology Letters 2001; 76:145–152.
14. Leite-de-Moraes MC, Lisbonne M, Arnould A, Machavoine F, Herbelin A, Dy M, Schneider E. Ligand-activated natural killer T lymphocytes promptly produce IL-3 and GM-CSF in vivo: relevance to peripheral myeloid recruitment. Eur J Immunol. 2002; 32(7): 1897-904.
15. Lemoli RM, D’Addio A, Hematopoietic stem cell mobilization. Haematologica 2008; 93(3): 321-324
16. Lord B, Molineux G, Pojda Z, Souza L, Mermod J, Dexter T et al. Myeloid cell kinetics in mice treated with recombinant interleukin-3, granulocyte colony-stimulating factor (CSF), or granulocyte-macrophage CSF in vivo. Blood 1991; 77: 2154–2159.
17. Mackaness GB. The immunological basis of acquired cellular resistance. J Exp Med 1964; 120: 105–20.
18. Ogiu T, Odashima S. Induction of rat leukemias and thymic lymphoma by N-nitrosourea. Acta Pathol Jpn 1982; 32 Suppl 1: 223- 35.
19. Palathumpat V, Dejbakhsh-Jones S, Strober S. The role of purified CD8+ T cells in graft-versus-leukemia activity and engraftment after allogeneic bone marrow transplantation. Transplantation 1995; 60(4): 355-61.
20. Stahl CP, Winton EF, Monroe MC, Hoff E, Holman RC, Myers L, et al. Differential effects of sequential, simultaneous, and single agent interleukin-3 and granulocyte-macrophage colonystimulating factor on megakaryocyte maturation and platelet response in primates. Blood 1992; 80: 2479-2485.
21. Suárez-Álvarez B, López-Vázquez A, López-Larrea C. Mobilization And Homing Of Hematopoietic Stem Cells. Stem Cell Transplantation, edited by Carlos López-Larrea, Antonio LópezVázquez and Beatriz Suárez-Álvarez. Landes Bioscience / Springer Science+Business Media, LLC dual imprint / Springer series: Advances in Experimental Medicine and Biology 2012; 741.
22. Walker F, Roethke SK, Martin G. An overview of the rationale, process, and nursing implications of peripheral blood stem cell transplantation. Cancer Nurs. 1994; 17(2):141-148.
23. Yusuf N, Nasti TH, Katiyar SK, Jacobs MK, Seibert MD, Ginsburg AC, et al. Antagonistic roles of CD4+ and CD8+ T-cells in 7,12-dimethylbenz(a)anthracene cutaneous carcinogenesis. Cancer Res 2008; 68(10): 3924-30